Mapping and ablation solution suite for the treatment of atrial fibrillation

Cortex, now part of Boston Scientific, specializes in advanced medical technologies aimed at enhancing patient outcomes through innovative solutions. The company focuses on developing cutting-edge devices and systems that leverage data analytics and artificial intelligence to improve clinical decision-making and streamline healthcare processes. Their product pipeline includes a range of minimally invasive tools designed for various medical applications, emphasizing safety, efficacy, and user-friendliness for healthcare professionals.

The technologies employed by Cortex are rooted in a strong foundation of scientific research and engineering excellence. Their solutions often integrate real-time monitoring and feedback mechanisms, allowing for precise interventions during medical procedures. Additionally, Cortex emphasizes the importance of collaboration with healthcare providers to ensure that their products meet the evolving needs of the medical community, ultimately aiming to enhance patient care and operational efficiency in healthcare settings.

United States

Cortex aims to transform the diagnosis and treatment of atrial arrhythmias by providing insight into each individual patient's disease pathophysiology. The OptiMap™ System is a 510k cleared, electrographic flow mapping solution designed with AI, enabling physicians to See What Matters.

Cortex - acquired by Boston Scientific

Company Details